耕深电子测量和显示装置的设计与试验研究

提出了一种基于角度传感器自动测量农机具耕深的方法。以悬挂机构位置和提升臂转角的几何对应关系为基础,通过检测提升臂的转角变化,推导出耕深值与测量电压值之间的线性关系并换算得到实际耕深。相对于其他耕深检测方式,该方法具有集成度高、封装小、安装和维护方便的特点。安装在驾驶室里的显示模块可为使用者提供实时数据,有利于使用者及时调整耕深,以保证拖拉机翻耕的质量。     

Increased humoral antibody response of foot-and-mouth disease virus vaccine in growing pigs pre-treated with poly-γ-glutamic acid

This study was conducted to determine if humoral antibody response of foot-and-mouth disease (FMD) vaccine improved in 8-week-old growing pigs born to well-vaccinated sows pre-treated with 60 mg of poly-γ-glutamic acid (γ-PGA) three days before vaccination. Antibody against FMD virus serotype O was measured 0, 2, 4 and 6 weeks post-vaccination, using a PrioCHECK FMDV type O ELISA kit. The results showed that positive antibody reactions against FMDV serotype O antigen among a component of the vaccine significantly increased in response to pre-injection with γ-PGA.     

Comparison of two types of CIDR-based timed artificial insemination protocols for repeat breeder dairy cows

This study compared two types of controlled internal drug release (CIDR)-based timed artificial insemination (TAI) protocol for treatment of repeat breeder dairy cows. In the first trial of the experiment, 55 repeat breeder cows were randomly assigned to the following two treatments. (1) In the EB group, a CIDR device was inserted into the cows, and then the cows were administered an injection of 1 mg estradiol benzoate (EB) plus 50 mg progesterone (P4; Day 0). On Day 7, they were given an injection of PGF(2alpha) and the CIDR device was removed. The cows were given an injection of 1 mg EB on Day 8 and were subjected to TAI 30 h later (n=27). (2) In the gonadotrophin releasing hormone (GnRH) group, a CIDR device was inserted into the cows, and then the cows were administered an injection of 250 microg gonadorelin (GnRH; Day 0). On Day 7, they were given an injection of PGF(2alpha) and the CIDR device was removed. The cows were given an injection of 250 microg GnRH on Day 9 and were subjected to TAI 17 h later (n=28). In the second trial, 41 repeat breeder cows that were confirmed as not pregnant in the first trial were randomly assigned to the same two treatments used in the first trial (an EB group of 20 cows and a GnRH group of 21 cows). The ovaries of 15 cows from each group were examined by transrectal ultrasonography in order to observe the changes in ovarian structures, and blood samples were collected for analysis of serum P4 concentrations. The pregnancy rates following TAI in the first (18.5 vs. 32.1%) and second (40.0 vs. 38.1%) trials and the combined rates (27.7 vs. 34.7%) did not differ between the EB and GnRH groups. The proportions of cows with follicular wave emergence within 7 days did not differ between the EB (12/15) and GnRH groups (13/15). The interval to wave emergence was shorter (P<0.01) in the GnRH group than in the EB group, but there was no difference in the mean diameters of dominant follicles on Day 7 between the groups. Moreover, the proportions of cows with synchronized ovulation following a second EB or GnRH treatment did not differ between the groups. In conclusion, treatment with either EB or GnRH in a CIDR-based TAI protocol results in synchronous follicular wave emergence, follicular development, synchronous ovulation, and similar pregnancy rates for TAI in repeat breeder cows.     

Therapeutic trial of granulocyte-colony stimulating factor for dilated cardiomyopathy in three dogs

Three dogs were presented to us for evaluation of cardiac problems. Electrocardiographic recordings revealed severe tachyarrhythmia and atrial fibrillation with ventricular tachycardia in 2 of the 3 dogs. The echocardiographic findings of the 3 dogs revealed markedly decreased fractional shortening and a marked increase in E-point septal separation. Based on the results of electrocardiographic and echocardiographic evaluation, the 3 dogs were diagnosed as dilated cardiomyopathy (DCM). The dogs were treated with conventional cardiac medication, but cardiac function did not improve and the clinical signs remained. We subsequently attempted treatment with granulocyte-colony stimulating factor (G-CSF; 10 microg/kg, subcutaneously). The specific purpose of G-CSF therapy for DCM was to improve cardiac function and a significant improvement in cardiac function was confirmed. The three dogs had no treatment side effects. This case report suggests that G-CSF might have therapeutic effects for medically refractory DCM in dogs.     

Glutathione content of in vivo and in vitro matured canine oocytes collected from different reproductive stages

Glutathione (GSH) concentrations of oocytes are considered as an important marker of the cytoplasmic maturation. The present study was designed to compare GSH concentrations of in vivo and in vitro matured canine oocytes. In vivo matured oocytes were collected 72 hr after ovulation by flushing fallopian tubes after laparotomy. Ovaries were collected from bitches with different reproductive stages, and collected oocytes were divided into 2 groups according to the size viz. < 120 microm and > 120 microm in diameter and cultured for 72 hr in Tissue Culture Medium-199 supplemented with 10% FBS, 2.2 mg/ml sodium bicarbonate, 2.0 microg/ml estrogen, 0.5 microg/ml FSH, 0.03 IU/ml hCG, and 1% penicillin-streptomycin solution in the presence or absence of 50 microM beta-mercaptoethanol. GSH concentrations were determined by the dithionitrobenzoic acid-glutathione disulfide (DTNB-GSSG) reductase recycling assay. GSH concentrations of immature canine oocytes were 2.9 and 3.8, 3.5 and 6.8, and 3.1 and 6.5 pM/oocyte for < 120 microm and > 120 microm in diameter oocyte groups at anestrous, follicular and luteal stage, respectively (P<0.05). In vivo matured oocytes had significantly higher GSH concentrations compared with in vitro matured oocytes. The GSH content was 19.2 pM/oocyte for in vivo matured oocytes, while 4.1 to 8.1 and 5.7 to 13.2 pM/oocyte for in vitro matured oocytes cultured in the absence or presence of beta-mercaptoethanol, respectively (P<0.05). Presence of beta-mercaptoethanol increased GSH synthesis in canine oocytes cultured in vitro, and oocytes collected from follicular and luteal stage was superior to anestrus oocytes.     

生物杀虫剂组合在有机水稻种植中的作用效果

针对上海市崇明区有机水稻生产过程中病虫害防治效果不佳的问题,在水稻无化肥、无化学农药种植条件下开展了生物杀虫剂对水稻主要害虫稻纵卷叶螟和稻飞虱的田间防控效果评价。在崇明区的2个试验基地,于水稻不同生长时期,以绿僵菌、白僵菌产品分别与病毒杀虫剂MbNPV、植物源杀虫剂苦参碱和细菌杀虫剂Bt组合进行施药处理。结果表明,应用绿僵菌/白僵菌与MbNPV组合,能够有效防治稻纵卷叶螟,在稻纵卷叶螟发生较早的基地,施药后7 d和14 d的防效可达58.2%～81.2%,而在稻纵卷叶螟发生较晚的另一基地,施药后7 d防效可达61.3%和65.6%;绿僵菌/白僵菌与苦参碱组合,可用于防治稻飞虱,7 d和14 d的防效达64.7%～76.1%;绿僵菌/白僵菌与苏云金杆菌组合防治稻纵卷叶螟的14 d防效分别达64.0%和75.4%,优于对稻飞虱的防效;各组合试验结果显示,白僵菌有相对较长的持效作用,且在害虫迁入早期阶段(水稻发育分蘖盛期至拔节期)施用生物农药比在中后期(抽穗期及之后)施用的防效高。可见,生物杀虫剂组合可作为农作物绿色防控的有效手段。     

苹果轮纹病菌对吡唑醚菌酯的敏感性及Cytb基因序列分析

为了明确苹果轮纹病菌Botryosphaeria dothidea对吡唑醚菌酯的敏感性和吡唑醚菌酯的靶标基因序列, 采用菌丝生长速率法测定了水杨肟酸对B. dothidea 菌丝生长的作用, 探讨了添加或不添加水杨肟酸的情况下病原菌对吡唑醚菌酯敏感性的变化; 并测定了不同产区的80株B. dothidea 对吡唑醚菌酯的敏感性以及440株B. dothidea 对吡唑醚菌酯的抗性; 然后, 扩增并分析了具有不同敏感性的菌株的细胞色素b基因 (Cytb) 序列?结果表明:不同浓度水杨肟酸对菌丝生长的抑制作用不同?添加40 μg/mL水杨肟酸不影响吡唑醚菌酯的EC50?菌株的敏感性频率符合近似正态分布, 各产区菌株对吡唑醚菌酯的敏感性没有显著差异, 吡唑醚菌酯平均EC50为(2.95±2.11) μg/mL, 没有检测到抗性菌株?靶标基因序列分析表明, Cytb基因在F129?G137和G143位密码子上没有产生点突变, 首次发现在143位密码子后有内含子插入?